Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:covers |
biopharmaceuticals
|
| gptkbp:hasAbstract |
The invention relates to methods for producing recombinant proteins.
|
| gptkbp:hasAssignee |
gptkb:Genentech,_Inc.
|
| gptkbp:hasCitations |
gptkb:US_6,455,275
gptkb:US_6,200,806 US 6,187,202 US 6,528,628 US_6,013,463 |
| gptkbp:hasClaim |
20 claims
|
| gptkbp:hasFieldOfUse |
medical research
|
| gptkbp:hasFilingDate |
2004-02-06
|
| gptkbp:hasPatentNumber |
6,789,298
|
| gptkbp:hasPriorityDate |
2004-09-14
2003-02-06 |
| gptkbp:hasTitle |
Method for producing a recombinant protein
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,298 C19
|
| gptkbp:isAssignedTo |
gptkb:Roche_Holding_AG
|
| gptkbp:isFiledIn |
gptkb:United_States
|
| gptkbp:isMonitoredBy |
gptkb:John_Doe
|
| gptkbp:isPartOf |
biotechnology field
|
| gptkbp:isPublishedIn |
USPTO database
|
| gptkbp:isRelatedTo |
molecular biology
clinical trials gene expression gene therapy medical devices protein synthesis regulatory approval clinical research intellectual property therapeutic strategies vaccines diagnostic tools monoclonal antibodies pharmaceutical development cell culture pharmaceutical formulations therapeutic development therapeutic efficacy therapeutic antibodies therapeutic proteins market authorization safety testing biological assays commercialization recombinant DNA technology disease treatment protein purification bioprocessing biomanufacturing protein engineering biotechnology innovations transgenic organisms patient treatment biopharmaceutical manufacturing biological products recombinant vaccines cell line development efficacy testing healthcare_applications healthcare_innovations |
| gptkbp:isUsedFor |
therapeutic applications
|